Kiniksa Pharmaceuticals International Plc (KNSA)
48.46
+0.08
(+0.17%)
USD |
NASDAQ |
Jun 01, 16:00
48.46
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Market Cap : 3.728B for June 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Autolus Therapeutics Plc | 492.37M |
| Barinthus Biotherapeutics Plc | 27.81M |
| Scancell Holdings Plc | 336.14M |
| OptiBiotix Health Plc | 11.36M |
| Aurinia Pharmaceuticals, Inc. | 1.970B |
Market Cap Related Metrics
| PE Ratio | 53.41 |
| PS Ratio | 5.173 |
| Price to Book Value | 6.156 |
| Price to Free Cash Flow | 23.75 |
| Price | 48.46 |
| Earnings Yield | 1.87% |
| Operating PE Ratio | 41.84 |
| Normalized PE Ratio | 53.41 |